RT Book, Section
A1 Mueller, Scott W.
A1 Fish, Douglas N.
A2 DiPiro, Joseph T.
A2 Talbert, Robert L.
A2 Yee, Gary C.
A2 Matzke, Gary R.
A2 Wells, Barbara G.
A2 Posey, L. Michael
SR Print(0)
ID 1153484935
T1 Infections in Immunocompromised Patients
T2 Pharmacotherapy: A Pathophysiologic Approach, 10e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259587481
LK accesspharmacy.mhmedical.com/content.aspx?aid=1153484935
RD 2022/05/29
AB Content  UpdateMay  16,  2018ASCO  and  IDSA  Practice  Guideline  Update  on  Outpatient  Management  of  Febrile  Neutropenia  in  Adults  with  Cancer:  An  expert  panel  of  the  American  Society  of  Clinical  Oncology  (ASCO)  and  the  Infectious  Diseases  Society  of  America  (IDSA)  conducted  a  systematic  review  and  provided  updated  recommendations  for  outpatient  evaluation  and  treatment  of  fever  and  neutropenia  in  adults  treated  for  malignancy.  The  guideline  was  developed  to  assist  healthcare  providers  in  identifying  appropriate  patient  candidates  for  outpatient  management  of  fever  and  neutropenia  based  on  clinical  criteria  and  validated  scoring  systems.  Clinicians  must  inform  patients  about  safety  practices  and  patient/caregiver  responsibilities  after  discharge  because  they  have  important  roles  in  ensuring  the  safe  and  effective  outpatient  management  of  febrile  neutropenia.